Merger of Axis Biochemicals ASA (NO) and Shield Diagnostics (UK) — NOK 970 million

Carnegie acted as adviser to Axis Biochemicals ASA in the merger with Scottish diagnostic company Shield Diagnostics. The combined entity is a significant in-vitro diagnostics company listed in Oslo and London. June, 1999.